Home / Markets / News / Cadila Healthcare slips 4.5% from day's high post June quarter results

Cadila Healthcare slips 4.5% from day's high post June quarter results

The stock of the pharmaceutical firm declined 4.5 per cent from its intra-day high of Rs 411.60, also its 52-week high, touched earlier in the day.

Premium

The company's consolidated revenue grew 4 per cent on a yearly basis to Rs 3,639.9 crore, compared to Rs 3,496.3 crore reported in the June quarter of FY20

SI Reporter New Delhi

3 min read Last Updated : Aug 05 2020 | 2:03 PM IST

Shares of Cadila Healthcare slipped 2.4 per cent to Rs 392.85 on the BSE on Wednesday after the company reported flat operational performance in April-June quarter of FY20. The stock of the pharmaceutical firm declined 4.5 per cent from its intra-day high of Rs 411.60, also its 52-week high, touched earlier in the day.

The company's consolidated revenue grew 4 per cent on a yearly basis to Rs 3,639.9 crore, compared to Rs 3,496.3 crore reported in the June quarter of FY20. Sequentially, the revenue from operations dipped 3 per cent from Rs 3,752.1 crore logged in Q4FY20.

The company's India business

Topics : Buzzing stocks Cadila Healthcare Markets

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in